Atreca Stock (OTC:BCEL), Quotes and News Summary

Q: What sector and industry does Atreca (BCEL) operate in?

Atreca is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Atreca Stock (OTC: BCEL) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.075M
Day Range	- - -
52 Wk Range	0.052 - 1.264
Market Cap	$2.696M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

Avi Kapoor

Gold Moves Lower; Phunware Shares Plummet

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded down 0.04% to 37,345.91 while the NASDAQ fell 0.86% to 14,815.87. The S&P 500 also fell, dropping, 0.47% to 4,743.45.

Avi Kapoor

Nasdaq Down Over 200 Points; US Retail Sales Increase 0.6% In December

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 200 points on Wednesday. Following the market opening, the Dow traded down 0.26% to 37,264.12 while the NASDAQ fell 1.54% to 14,714.00. The S&P 500 also fell, dropping, 0.81% to 4,727.51.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

2.6

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Atreca Inc

Sector

Health Care

Industry

Biotechnology

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and deve...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Atreca (BCEL) stock?

You can purchase shares of Atreca (OTCPK: BCEL) through any online brokerage.

View our list of the best stock brokerages.

Who are Atreca's (BCEL) competitors?

There are no as such competitors for Atreca.

What is the target price for Atreca (BCEL) stock?

The latest price target for Atreca (OTCPK: BCEL) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 1.00 expecting BCEL to rise to within 12 months (a possible 1076.47% upside). 6 analyst firms have reported ratings in the last year.

Current Stock Price for Atreca (BCEL)?

The stock price for Atreca (OTCPK: BCEL) is $0.085 last updated April 24, 2024 at 3:00 PM EDT.

Does Atreca (BCEL) pay a dividend?

There are no upcoming dividends for Atreca.

When is Atreca (OTCPK:BCEL) reporting earnings?

Atreca’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Atreca (BCEL) going to split?

There is no upcoming split for Atreca.

What sector and industry does Atreca (BCEL) operate in?

Atreca is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.